We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

InfanDx AG, LSI Initiates Clinical Study

News   May 21, 2016

 
InfanDx AG, LSI Initiates Clinical Study
 
 
Advertisement
 

RELATED ARTICLES

Altering Roundworm Proteins To Develop Anti-Aging Drugs

News

Researchers have been able to alter creatures’ lifespans by altering the activity of proteins found in roundworm cells that tell them to convert sugar into energy when their cellular energy is running low. Humans also have these proteins, offering up intriguing possibilities for developing longevity-promoting drugs.

READ MORE

Lab Profiles That Differentiate MIS-C From COVID-19 in Children Identified

News

Researchers from Children’s Hospital of Philadelphia report important data that differentiate MIS-C from severe COVID-19 in children and suggest that MIS-C is a post-infectious syndrome related to COVID-19 but distinct from KD.

READ MORE

Test Rapidly Determines Amount of SARS-CoV-2 Neutralizing Antibodies

News

A Swiss-German team has developed a test that determines the amount of SARS-CoV-2 neutralizing antibodies within a short period of time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE